
Darwin Private Equity makes first exit with Maxinutrition
Darwin Private Equity, founded in 2007 by former executives from Permira and CVC, has made its first exit with the ТЃ162m sale of sports nutrition company Maxinutrition to GlaxoSmithKline.
If approved by the OFT, Darwin says the sale will represent a successful conclusion to an investment that was made exactly three years ago. Darwin Private Equity acquired the business in a £75m secondary buyout from Piper Private Equity. The latter, Maximuscle's first private equity backer. itself generated a 10x return on its £3.2m commitment to the funding of the firm's initial BIMBO in 2004.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Julian Longhurst on +44 20 7004 7449 or julian.longhurst@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds